Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression

EV-DNA独特的结构构型可启动库普弗细胞介导的抗肿瘤免疫,从而阻止转移进展。

阅读:12
作者:Inbal Wortzel ,Yura Seo # ,Ife Akano # ,Lee Shaashua ,Gabriel Cardial Tobias ,Jakob Hebert ,Kyung-A Kim ,DooA Kim ,Shani Dror ,Yanshen Liu ,Griffin Campbell Azrak ,Michele Cioffi ,Kofi Ennu Johnson ,Tammy Hennika ,Meshulam Zisha Twerski ,Alexis Kushner ,Robert Math ,Yoon Dae Han ,Dai Hoon Han ,Minsun Jung ,Juyeong Park ,Soonmyung Paik ,Jeon-Soo Shin ,Min Goo Lee ,Marco Vincenzo Russo ,Daniel Zakheim ,Jesse Barnes ,Sunjoy Mehta ,Katia Manova ,Robert E Schwartz ,Basant Kumar Thakur ,Nancy Boudreau ,Irina Matei ,Haiying Zhang ,Simone Sidoli ,Jacqueline Bromberg ,Yael David ,Han Sang Kim ,David Lyden

Abstract

Extracellular vesicles (EVs) transport biomolecules that mediate intercellular communication. We previously showed that EVs contain DNA (EV-DNA) representing the entire genome. However, the mechanism of genomic EV-DNA packaging and its role in cancer remain elusive. We now demonstrate that EV-DNA is predominantly localized on the vesicle surface and associated with uniquely modified and cleaved histones. Moreover, a genome-wide clustered regularly interspaced short palindromic repeats knockout screen revealed that immune developmental pathways and genes, including apoptotic peptidase activating factor 1 (APAF1) and neutrophil cytosolic factor 1 (NCF1), regulate EV-DNA packaging. Furthermore, in colorectal cancer models, uptake of EV-DNA by pre-metastatic liver Kupffer cells (KCs) activated DNA damage responses. This activation rewired KC cytokine production and promoted the formation of tertiary lymphoid structures, thereby suppressing liver metastasis. Conversely, loss of APAF1 decreased EV-DNA packaging and promoted liver metastasis. Importantly, colorectal cancer biopsy EV-DNA secretion could serve as a predictive biomarker for postoperative metastasis. Taken together, our findings indicate that uniquely chromatinized EV-DNA induces antitumor immunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。